The FDA will require GSK and Pfizer to include on the label of their respiratory syncytial virus (RSV) vaccines a warning ...

Respiratory syncytial virus (RSV) is a common viral infection that may lead to serious complications in certain groups. Since 2023, vaccines are now available and are highly recommended ...

Live-attenuated respiratory syncytial virus (RSV) vaccines are highly immunogenic among HIV-exposed uninfected (HEU) pediatric patients, according to results of a study published in Open Forum ...

Pregnant women across Australia will be offered a free vaccine to protect their babies against respiratory syncytial virus (RSV) from next month. The government's $174.5 million investment will ...

The prescribing information for Abrysvo ® (respiratory syncytial virus [RSV] vaccine) and Arexvy ® (RSV vaccine, adjuvanted) has been updated to include a new warning regarding the risk of ...

Additionally, just 44.5% of adults ages 75 and older have received the RSV vaccine, according to CDC data. A health professional is seen vaccinating a person. STOCK PHOTO/Adobe Stock Nearly half ...

Expecting Aussie mums will be entitled to a free vaccine to protect their children from a dangerous virus, as part of a major government health shake-up. RSV commonly causes respiratory infections ...

When given to expectant mothers, the vaccine is expected to also protect their babies until they are six months old. Respiratory syncytial virus causes cold-like symptoms for many people but ...

Additionally, just 44.5% of adults ages 75 and older have received the RSV vaccine, according to CDC data. Nearly half of all children are vaccinated against the flu at 42.9%, but just 11% have ...